We are live on
!
Find out more
WEC
Winslow Evans & Crocker Portfolio holdings
AUM
$528M
1-Year Est. Return
30.99%
This Fund
S&P 500
This Quarter
Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
–
AUM
$365M
AUM Growth
+$46.1M
(+14%)
Cap. Flow
+$37.6M
Cap. Flow
% of AUM
10.3%
Top 10 Holdings %
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.28M |
| 2 |
Automatic Data Processing
ADP
|
+$2.29M |
| 3 |
Amazon
AMZN
|
+$1.57M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.47M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.44M |
| 2 |
Oracle
ORCL
|
+$1.05M |
| 3 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$657K |
| 4 |
HDFC Bank
HDB
|
+$522K |
| 5 |
Boeing
BA
|
+$473K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.43% |
| 2 | Healthcare | 11.88% |
| 3 | Financials | 10.98% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Energy | 7.89% |
Similar funds
PJB
IVA
TAM
PSSGI
AVAX
DK
MCM
GBBWRPM
Winslow Evans & Crocker's Q2 2017 Portfolio in Review
As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.
- Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
- Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
- Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
- Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
- Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
- Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
- Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.
Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.